Christian from Romania

Registered at the short selling broker StormGain, 4 minutes ago.

» Try StormGain you too
There is no percentage of traders loosing on crypto platforms.
Don't show again

Theseus Pharmaceuticals Inc (THRX) shares information

Theseus Pharmaceuticals Inc


24h Change

0.51 %

THRX

Live rate: Market closed

Stock data per Friday 21 Jan, 2022

THRX
NASDAQ
9.91
9.71
9.96
0.05 (+ 0.51%)
US Market is closed

Live Stock price in graph for Theseus Pharmaceuticals Inc (THRX)

  • Latest Volume

    217,105 (13.51 %)

  • Volume prev. day

    191,269

  • Avg. daily volume

    181,102

  • Market cap

    385,478,394

  • P/E ratio

    n/a

  • Today high

    10.275 USD

  • Today low

    9.455 USD

  • 52 week high

    24.54 USD

  • 52 week low

    8.65 USD

  • YTD Change

    n/a

Quick links

 

Latest news about Theseus Pharmaceuticals Inc

Below you can find the most recent news posts about Theseus Pharmaceuticals Inc, primarily from US and UK based news sources.

Theseus Pharmaceuticals Inc Shares Close the Day 23.2% Higher – Daily Wrap

Monday, 17 January 2022, 05:11:53
Theseus Pharmaceuticals Inc (THRX) shares closed today 23.2% higher than it did at the end of yesterday. The stock is currently down 7.5% year-to-date, down 36.9% over the past 12 months, and down 36.9% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $11.75 and as low as $9.01 this week.Shares closed 52.2% below its 52-week high and 35.6% above its 52-week low.Trading volume this week was 50.7% lower than the 10-day average and 65.7% lower than the 30-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -1040.9% The company's stock price performance over the past 12 months lags the peer average by -310.5%

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected] © 2020 Kwhen Inc.


— Kwhen Finance


Theseus Pharmaceuticals Inc Shares Close the Day 23.2% Higher – Daily Wrap

Saturday, 15 January 2022, 15:55:23
Theseus Pharmaceuticals Inc (THRX) shares closed today 23.2% higher than it did at the end of yesterday. The stock is currently down 7.5% year-to-date, down 36.9% over the past 12 months, and down 36.9% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $11.75 and as low as $9.01 this week.Shares closed 52.2% below its 52-week high and 35.6% above its 52-week low.Trading volume this week was 51.5% lower than the 10-day average and 75.9% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -1040.9% The company's stock price performance over the past 12 months lags the peer average by -303.2%

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected] © 2020 Kwhen Inc.


— Kwhen Finance


Theseus Pharma gains after insider purchase (NASDAQ:THRX)

Friday, 14 January 2022, 17:25:34
Recently IPOed biopharmaceutical company Theseus Pharmaceuticals <> has added more than a tenth in value on below-average volume after the investment manager OrbiMed
— Seeking Alpha


Theseus Pharmaceuticals Inc Shares Close the Week 22.5% Lower – Weekly Wrap

Monday, 10 January 2022, 18:05:48
Theseus Pharmaceuticals Inc (THRX) shares closed this week 22.5% lower than it did at the end of last week. The stock is currently down 22.5% year-to-date, down 47.1% over the past 12 months, and down 47.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Shares traded as high as $12.62 and as low as $9.16 this week.Trading volume this week was 10.7% lower than the 10-day average and 60.0% lower than the 30-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -4869.0% The company's stock price performance over the past 12 months lags the peer average by -369.5%

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected] © 2020 Kwhen Inc.


— Kwhen Finance


Theseus Pharmaceuticals Inc Shares Close the Day 24.1% Higher – Daily Wrap

Sunday, 26 December 2021, 05:50:42
Theseus Pharmaceuticals Inc (THRX) shares closed today 24.1% higher than it did at the end of yesterday. The stock is currently down 40.0% year-to-date, down 40.0% over the past 12 months, and down 40.0% over the past five years. Today, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 0.6%. Trading Activity Shares traded as high as $12.15 and as low as $8.65 this week.Shares closed 54.6% below its 52-week high and 28.8% above its 52-week low.Trading volume this week was 66.6% lower than the 10-day average and 37.0% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected] © 2020 Kwhen Inc.


— Kwhen Finance


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have THRX available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.